In conclusion, our findings suggest relevant roles of E-selectin, ICAM-1, and ET-1 in RA-ILD+ as well as of ICAM-1 in SSc-ILD+, supporting their utility as potential screening blood biomarkers of subclinical ILD in AD, contributing to the early diagnosis of the disease. This evidence concerns the gene ICAM1 and systemic sclerosis.